If you or a loved one is facing cancer, you may be exploring natural and complementary therapies that could improve treatment outcomes and support overall health. While many natural products are marketed as anticancer or immune-boosting remedies, most lack strong scientific evidence and may even pose risks in certain situations.
Mistletoe, however, stands out as one of the most researched complementary cancer therapies used worldwide. It is a semi-parasitic plant that grows on various trees and has been studied extensively for its potential role in oncology.
Recent observational studies have shown that patients with late-stage non-small cell lung cancer (NSCLC) who received Mistletoe Therapy alongside chemotherapy lived significantly longer than those who had chemotherapy alone.
Today, Mistletoe Therapy is recognized as the second most widely studied cancer treatment after conventional therapies, with more than 130 clinical trials and over 3,000 published research papers supporting its use.
Mistletoe (Viscum album L.) is a semi-parasitic evergreen plant that grows on various trees, drawing nutrients and water from its host. For more than a century, mistletoe extracts have been used in integrative cancer care, especially in Europe. Research suggests that it may help support the immune system, reduce side effects of conventional treatments, and improve quality of life. Mistletoe is most often given as injections under the skin, sometimes continuing for weeks or months. It remains one of the most widely studied complementary cancer therapies, with hundreds of clinical trials and thousands of published studies.
Our patented oral mistletoe extract is specially formulated with the highest levels of lectins, viscotoxins, and polysaccharides—natural compounds that help the body fight cancer more effectively. These compounds work by triggering apoptosis (the natural death of cancer cells) and strengthening the immune system’s ability to defend against disease.
Research has shown that mistletoe extracts can boost immunity, support the body’s healing response, and help reduce the side effects of conventional cancer treatments. Patients often report improved energy, reduced discomfort, and better overall well-being.
At the Indian Institute of Integrative Oncology (IIIO), we provide mistletoe in enteric-coated tablets (250mg, 350mg, and 500mg) for maximum absorption and bioavailability. This ensures that patients receive the full therapeutic benefits for both cancer cell targeting and immune system support.
→ Basic research shows that Mistletoe extracts may stimulate the immune system to fight cancer.
→ Studies in humans show that Mistletoe treatment may improve symptoms and reduce side effects of cancer treatments.
→ There are sufficient evidences to prove that Mistletoe can be used as supportive therapy in cancer care.
→ Researchers found that Mistletoe extracts could boost survival rates among people with cancer.
→ Other studies suggest that Mistletoe may reduce tumor growth and support the immune system.